PEGylated Polyethylenimine as Enhanced T1 Contrast Agent for Efficient Magnetic Resonance Imaging
Lists
Only you see this
Abstract
Currently used small molecular magnetic resonance (MR) imaging contrast agents (CAs) in clinics have relatively short half-lives, which has limited the acquisition of high-resolution organ and angiographic images. Therefore, development of a facile strategy for the synthesis of long-circulating CAs with the transforming potential for MR imaging still remains a great challenge. Here we communicate the design and synthesis of PEGylated polyethylenimine (PEI) and its application as enhanced T1 CA for the long-circulating blood pool as well as efficient organ and tumor imaging. In this study, PEI was covalently grafted with gadolinium (Gd(III)) chelator and mPEG-NHS, followed by acetylation of the remaining amines to improve biocompatibility and prolong circulation time. With the relatively long circulation time (3.8 h), the formed multifunctional PEI (PEI.NHAc-DTPA(Gd(III))-mPEG) can be used as an enhanced T1 CA for blood pool and major organ imaging, and could be cleared from the body 96 h post administration through the urinary system. Importantly, the PEI.NHAc-DTPA(Gd(III))-mPEG complexes displayed a strong T1 contrast effect for tumor imaging through the enhanced permeation and retention effect. These findings suggest that the synthesized PEI.NHAc-DTPA(Gd(III))-mPEG may be used as a promising CA for T1 MR imaging of various biological systems.
BibTeX
@inproceedings{zhou2014pegylated,
author = {Shengyuan Zhou and Zhenkai Wu and Xiongsheng Chen and Lianshun Jia and Wei Zhu},
title = {{PEGylated Polyethylenimine as Enhanced T<sub>1</sub> Contrast Agent for Efficient Magnetic Resonance Imaging}},
booktitle = {ACS},
year = {2014},
doi = {10.1021/am5020875},
}Loading related content...